Rubicon Genomics Enters Next-Gen Sequencing Sample-Prep Market with Single-Cell Sequencing Kit

The company is focused primarily on developing tools to analyze clinical samples, and is targeting applications such as non-invasive prenatal diagnostics, circulating tumor cells and tumor progression, and infectious disease.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.